Brickell Biotech Stock
Brickell Biotech is focused on the acquisition, development, and commercialization of drug therapies for the treatment of skin diseases.
About Brickell Biotech Stock
Brickell Biotech, Inc., a Delaware corporation, is a development-stage pharmaceutical company focused on the acquisition, development and commercialization of innovative drug therapies for the treatment of skin diseases.
Co-Founder and President
President and Chief Scientific Officer
Chief Financial Officer
Vice President, New Product Development
Vice President, Product Development
Vice President, Chemistry, Manufacturing, and Controls
Co-Founder and Vice President, Operations
Senior Vice President, Global Regulatory Affairs
Business Wire (press release) - Oct, 24 2017